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Abstract
Moraxella catarrhalis is a Gram negative bacterium and a leading causative agent of otitis media (OM) in children. Several
recent reports have provided strong evidence for an association between toll like receptors and OM. It has been found that
both Streptococcus pneumoniae and nontypeable Haemophilus influenzae activate host protective immune responses
through toll like receptors (TLRs), however, the precise mechanism by which Moraxella catarrhalis initiates the host immune
response is currently unknown. In this report, using murine macrophages generated from a series of knock-out mice, we
have demonstrated that M. catarrhalis lipooligosaccharide (LOS) and either heat killed or live bacteria are recognized by one
or more TLRs. LOS activates the host immune response through a membrane bound CD14-TLR4 complex, while both heat
killed and live M.cat require recognition by multiple toll like receptors such as TLR2, TLR4 and TLR9 without the requirement
of CD14. We have also shown that M.cat stimuli are capable of triggering the host innate immune response by both MyD88-
and TRIF- dependent signaling pathways. We further showed that M.cat induced activation of mitogen activated protein
kinase (MAPK) is essential in order to achieve optimal secretion of pro-inflammatory cytokine TNF-a. We finally showed that
TLR4 mutant C3H/HeJ mice produce significantly lower levels of pro-inflammatory cytokines TNF-a and IL-6 in vivo,A n
increased bacterial loads at 12 and 24 hours (P,0.001) in their lungs upon challenge with live M.cat in an aerosol chamber
compared to wild-type (WT) control mice. These data suggest that TLRs are crucial for an effective innate immune response
induced by M.cat. The results of these studies contribute to an increased understanding of molecular mechanism and
possible novel treatment strategies for diseases caused by M.cat by specifically targeting TLRs and their signaling pathways.
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Introduction
The innate immune system is critical for the initiation of
effective immune response against invading pathogens. Toll like
receptors (TLRs) are pattern recognition receptors that can ‘sense’
a wide range of microbial products, provoke host responses and
produce various pro- and anti-inflammatory cytokines such as
TNF-a, IL-6, IL-12, IFN-c, NO, IL-10 etc. that trigger both
innate and adaptive immune responses [1]. So far, 10 TLRs in
human and 12 TLRs in mice have been identified. Lipopeptides
and other components of Gram positive bacteria are recognized
by TLR2 in conjunction with either TLR1 or TLR6, lipopoly-
sacharride (LPS) is recognized by TLR4, flagellin is detected by
TLR5, unmethylated DNA and CpG-oligodeoxynucleotides
(CpG-DNA) by TLR9, double-stranded RNA (dsRNA) or poly
I:C by TLR3 and single stranded RNA (ssRNA) by TLR7 and
TLR8 [2]. Most of the receptors that detect bacterial products are
located on cells surface (TLR2, TLR4, TLR5) while other
receptors that can sense nucleic acid are located in intracellular
compartments such as endosome (TLR3, TLR7, TLR8, TLR9)
[3]. Once TLRs recognize microbial products, they activate
distinct signaling pathways through different adaptor molecules
such as MyD88, Mal, TRIF and TRAM, leading to the activation
of various transcription factors (NF-kB, IRFs, AP-1 etc.) [4].
Among all the TLRs, only TLR4 has the unique ability to activate
both MyD88-dependent and the TRIF-dependent signaling
pathways, the later initiates the type-1 interferon response as well
as late NF-kB activation [5], [6].
Several clinical studies have shown the association between
TLRs and otitis media (OM). Lee et al. recently reported that
TLR2 and TLR4 are expressed in all the middle ear fluid samples
of OM with effusion, but found no correlation between the
expression of TLRs and concentration of immunoglobulin [7].
The same group also reported a significantly lower expression of
TLR9 in otitis-prone group than in non-otitis-prone group [8].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37610Gene expressions of TLR3, TLR4, TLR5 and TLR7 were
significantly lower in patients with chronic middle ear disease
compared to control patients [9]. On the other hand, increased
expressions of TLRs also have been reported. Granath et al. found
increased TLR7 expression in the adenoids of children with OM
with effusion [10]. Another study by Szczepanski et al. reported a
distinct expression of TLR2, TLR3, and TLR4 in tissues isolated
from human acquired cholesteatoma [11].
Until recently, Streptococcus pneumoniae was recognized as the
leading causative pathogen of OM; however, due to the
introduction of newly developed heptavalent pneumococcal
vaccine, the relative contribution of S. pneumoniae to OM has
changed and nontypeable Haemophilus influenzae (NTHi) has
become the leading cause of infection, and Moraxella catarrhalis
(M.cat) now ranks third. Mounting evidence suggests an active and
critical role of TLRs in OM. It has been reported that TLR2 and
p38 MAPK are important for NTHi induced NF-kB activation in
human epithelial cells [12]. In vivo studies with NTHi showed
distinct involvement of TLRs in different settings of animal
models. Van Der Poll and his colleagues found that MyD88-
dependent TLR4 signaling is important in clearing NTHi from
the mouse lung [13]. On the other hand, Ryan and colleagues
showed that deletion of TLR9 significantly prolonged the
inflammatory response induced by NTHi and delayed bacterial
clearance [14]. In a pneumococcal disease model, TLR2
2/2 mice
showed reduced clearance during later stages of pneumococcal
colonization. When S. pneumoniae were inoculated in the middle ear
of TLR2
2/2 mice, almost 50% of the mice died within 3 days of
inoculation compared to WT control mice. Of those TLR2
2/2
mice that survived, more severe hearing loss was observed [15].
Similar to TLR2, TLR4
2/2 and TLR9
2/2 mice also showed
higher bacterial loads and reduced survival against pneumococcal
infection [16,17].
Moraxella catarrhalis is an exclusive human pathogen and one of
the leading infectious agent that causes OM in children and also
found in patients with chronic obstructive pulmonary diseases
(COPD) [18], [19]. M.cat is responsible for 10%–20% of all
episodes of OM in infants and children [20], [21]. However,
compared to NTHi and S. pneumoniae, our knowledge about M.cat-
induced host immune response is lacking. Previously we reported
that the lipooligosaccharide (LOS), a key virulence factor of M.cat
activates human monocytes through CD14-TLR4 [22]. Schaar
et al. recently reported that outer membrane vesicles (OMV) of
M.cat initiate host responses through TLR2 [23]. M.cat also has the
ability to invade bronchial epithelial cells and primary airway
epithelial cells and initiates a TLR2 and partly NOD1-dependent
inflammatory response [24]. However, the details of the signaling
pathways that are activated by either M.cat LOS or whole bacteria,
to our knowledge, is not completely known. In the present study,
we found that LOS from M. cat is detected by murine
macrophages exclusively through CD14-TLR4 complex, while
other TLRs including TLR2 and TLR9, in addition of TLR4,
detect either heat-killed (HK) or live bacteria and induce pro-
inflammatory cytokines through both MyD88-dependent and
TRIF-dependent signaling pathways. Finally, we showed that in a
model of in vivo aerosol challenge of mice, the TLR4 mutant C3H/
HeJ strain produces significantly lower amounts of TNF-a and IL-
6 compared to WT C3H/OuJ mice and bacterial clearance was
significantly delayed at late time points in mutant mice. Together,
we have shown that TLR4 plays an important protective role
against M.cat infection.
Materials and Methods
Mice
Female mice, 6–8 wks old, were used for all experiments.
CD14
2/2 (strain name B6.129S-Cd14
tm1frm/J), TLR2
2/2 (strain
name B6.129-Tlr2
tm1Kir/J), TRIF
2/2 (strain name C57BL/6J-
Ticam1
Lps2/J), WT control C57BL/6J, LPS-unresponsive TLR4
mutant C3H/HeJ, and WT control C3H/OuJ mice, were
purchased from Jackson Laboratory, Bar Harbor, ME. TLR4
2/2
and MyD88
2/2 mice were originally described by Shizuo Akira
(University of Osaka, Japan) and were bred at the University of
Maryland, School of Medicine (Baltimore, MD, USA), and kindly
provided by Dr. Stefanie N. Vogel. These mice were backcrossed
onto a C57BL/6 background for $8 generations prior to use and
genotyped to ensure their genetic status. TLR2
2/2/TLR4
2/2/
TLR9
2/2 triple knock-out mice were generated by first crossing
TLR2 and TLR9 KO mice to generate TLR2/9 KO mice. The
presence of wild-type vs. TLR2 or TLR9 KO alleles was
determined for each offspring by PCR analysis of chromosomal
DNA isolated from whole blood. Once identified, the TLR2/9
KO mice were crossed with TLR2/4 KO mice to generate
TLR2/4/9 KO mice. The presence of wild-type vs. TLR2, TLR4
or TLR9 KO alleles was determined for each offspring by PCR
analysis of chromosomal DNA isolated from whole blood. All
experiments involving mice were performed according to the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Protocol
was reviewed and approved by institutional review board at the
National Institutes of Health (Permit Number: 1158).
Bacterial strain and purified LOS
M. catarrhalis strain 25238 (serotype A) was purchased from the
American Type Culture Collection (Manassas, VA). LOS purifi-
cation from type A strain has been described earlier [25]. The
protein and nucleic acid in purified LOS was less than 1%.
Reagents
Lipopolysaccharide (LPS) from E.coli 055:B5 was purchased
from Sigma Chemicals (St Louis, MO). The JNK1/2 inhibitor
(SP600125), p38 inhibitor (SB202190), and ERK1/2 inhibitor
(U0126) were obtained from Calbiochem (San Diego, CA). and
recombinant mouse M-CSF was purchased from R&D systems
(Minneapolis, MN). The TLR2 ligand ‘synthetic triacylated
lipoprotein’ (Pam3CSK4), the TLR3 ligand (poly I:C), and the
TLR9 ligand CpG DNA were purchased from InvivoGen (San-
Diego, CA).
Preparation of bone marrow-derived macrophage
Bone marrow-derived macrophages (BMMØ) were prepared as
described earlier [26], [27] with modification. Mouse tibias and
femurs were cut at both ends and flushed with RPMI 1640
medium containing 10% FBS. Harvested bone marrow cells were
cultured in the presence of murine recombinant M-CSF at 20 ng/
ml for 7 days at 37uC under 5% CO2. Every two days, media was
replaced with new media containing M-CSF at same concentra-
tion. At day 7, adherent macrophages were used for further
experiment (in the absence of M-CSF). Flow cytometric analysis
showed that .90% cells were CD11b-, F4/80- and MHC II-
positive.
Cell stimulation
BMMØ were stimulated with LOS (100 ng/ml) or with live
bacteria or heat-killed (HK) bacteria at a multiplicity of infection
(MOI) of 10 (bacteria:cells) in a complete culture media for 6–
M.cat Induced Innate Immune Response
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bacteria at 95uC for 45 min and complete killing was confirmed by
culturing the lysate on chocolate agar plates. After the indicated
time, macrophage culture supernatants were collected to detect
the presence of various cytokines. RNA was extracted from the
adherent cells by RNeasy mini spin column (Qiagen Sciences,
Germantown, MD) and used for real-time RT-PCR. For
experiments involving various MAP kinase inhibitors, total
splenocytes were isolated from TLR4
2/2 mice and cultured in
24 well tissue culture plate at 2610
5 cells/well. Prior to stimulation
with live or HK bacteria, cells were pretreated with p38 MAP
kinase inhibitor SB202190 (10 mM), JNK1/2 inhibitor SP600125
(10 mM) and ERK1/2 inhibitor U0126 (10 mM) for 1 h followed
by treatment with live or HK bacteria. After 18 h, culture
supernatants were collected and used for cytokines measurement.
For experiments involving various MAP kinase inhibitors,
splenocytes were isolated from WT or TLR4
2/2 mice and
cultured in 24 well tissue culture plate at 2610
5 cells/well. Prior to
stimulation with live or HK bacteria, cells were pretreated with
p38 MAP kinase inhibitor SB202190 (10 mM), JNK1/2 inhibitor
SP600125 (10 mM), or ERK1/2 inhibitor U0126 (10 mM) for 1 h
followed by treatment with live or HK bacteria. After 18 h, culture
supernatants were collected for cytokine measurement.
Detection of Cytokines by ELISA
The levels of TNF-a, IL-6, IL-12 p40, IFN-b, and IFN-c in
culture supernatants in response to LOS, live or HK M.cat were
determined using enzyme-linked immunosorbent assay (ELISA) kit
(R&D Systems, Minneapolis, MN) according to the manufactur-
er’s instruction.
Real time RT-PCR
Total RNA extracted from previous steps were used to generate
first-stand cDNA by TaqMan reverse transcriptase reagents
(Applied Biosystem, Foster city, CA) using Eppendorf Mastercy-
cler (Eppendorf, Hamburg, Germany). The reverse transcribed
cDNA were amplified and quantified using power SYBR green
PCR master mix by Step One plus real time PCR system (Applied
Biosystem) with specific primers according to the manufacturer’s
protocol. The primer sequences were used as follows: RANTES,
5-CTCACCATATGGCTCGGACA-3 (Forward primer), 5-
CTTCTCTGGGGCACACA-3 (Reverse Primer), Actin, 5-
AGCTGCGTTTTACACCCTTT-3 (Forward primer), 5-AAGC-
CATGCCAATGTTGTCT-3 (Reverse Primer). Following the
amplification, melting curve analysis was performed at tempera-
ture between 60uCt o9 5 uC.
Bacterial challenge and sampling
TLR4 mutant C3H/HeJ and control C3H/OuJ mice were
challenged with aerosolized M. catarrhalis strain 25238 at
1610
8 CFU/ml in an inhalation exposure system (Glas-Col,
LLC, Terre Haute, IN) as previously described [28]. At 3, 6, 12,
and 24 h post-challenge, mice were euthanized and lungs were
harvested and homogenized in 1 ml of phosphate buffered saline
(PBS) with a Precellys 24 homogenizer (Bertin Technologies, Paris,
France). Serially diluted lung homogenates were cultured on
chocolate agar plates overnight at 37uC with 5% CO2 to
determine colony forming units (CFU). The remainder of the
lung homogenates were used for cytokine measurements. Six mice
per strain were used at each time point.
Statistical analysis
Statistical significance was determined by student’s t-test.
Experimental results are expressed as the mean of duplicates 6
standard deviation in at least 2 independent experiments. The
pulmonary levels of viable bacterial counts were logarithm
transformed ((log)10 CFU) for statistical analysis. The difference
between the lung viable bacterial counts from wild-type and that
from TLR4 mice at each time point was analyzed by using
Student’s t-test.
Results
CD14-TLR4 contribute to initiate LOS-induced host
responses in murine macrophage
CD14 initiates the LPS signaling through a physical interaction
with TLR4-MD2 complex [29]. We first investigated the relative
contribution of CD14 in macrophages stimulated by LOS or by
HK and live M.cat. BMMØ generated from CD14
2/2 and WT
(C57BL/6J) mice were treated with M. cat LOS (100 ng/ml), E.
coli LPS (100 ng/ml), the TLR2 ligand Pam3CSK4 (10 mg/ml),
and live or HK M.cat for 6 hours and levels of TNF-a and IL-6 in
culture supernatants were measured using ELISA. Treatment with
both LPS and LOS resulted in secretion of TNF-a and IL-6 from
macrophages isolated from WT mice that was significantly
reduced in CD14-deficient macrophages (Fig. 1A–B). In contrast,
the induction of TNF-a and IL-6 by the TLR2 ligand was
completely CD14-independent yet induced roughly equivalent
levels of both TNF-a and IL-6 as the LPS and LOS. However,
WT and CD14
2/2 macrophages treated with live or HK M. cat
produced much greater levels of TNF-a, and IL-6 than the other
stimuli; however, TNF-a production was CD14-independent,
while IL-6 production was partially inhibited in CD14
2/2
macrophages compared to WT macrophages. Next we treated
total splenocytes from WT and CD14
2/2 mice in a similar fashion
and compared IFN-c secretion between these 5 treatments.
Similar to TNF-a and IL-6, IFN-c was poorly inducible in either
LPS- or LOS-treated WT macrophages, and not inducible in
CD14-deficient macrophages. CD14-deficient macrophages treat-
ed with live or HK M.cat showed strong production of IFN-c
compared to WT macrophages. As seen in Fig. 1A, B, a lack of
CD14 had no effect on Pam3CSK4- induced IFN-c secretion
(Fig. 1C).
Next, we investigated relative contribution of TLR4 in LOS- or
M. cat-induced macrophage responses. BMMØ generated from
TLR4
2/2 mice were treated as described above. Both LOS- and
LPS-induced production of TNF-a was completely abolished in
TLR4
2/2 macrophages compared to WT macrophages (Fig. 2A).
However, unlike CD14
2/2 macrophages, where no reduction of
TNF-a was seen in cells treated with either HK or live M. cat,w e
observed a modest reduction of TNF-a secretion in TLR4
2/2
macrophages compared to WT control cells. To confirm that
TLR4 signaling is only partially responsible for the HK- or live
M.cat-induced host response, we measured a second cytokine, IL-
12 p40, and obtained similar data (Fig. 2B). Together, these data
show that the CD14-TLR4 signaling axis is absolutely required for
the M. cat LOS-induced host response, but does not account fully
for the host response to either live or HK M. cat.
M.cat induced host response depends partially on TLR2
Although the cell wall of M. cat is mostly composed of LOS, it
also contains lipoproteins that may initiate cellular response
through TLR2. To determine the role of TLR2 in M.cat-induced
host responses, we generated BMMØ from TLR2
2/2 mice and
treated cells with LOS, LPS, HK and live M.cat for 6 hours and
M.cat Induced Innate Immune Response
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no significant differences observed in either LOS- or LPS-induced
TNF-a or IL-6 secretion between WT and TLR2
2/2 macro-
phages (Fig. 3A–B). These data confirm that TLR2 has no role in
LOS-induced host response. On the other hand, similar to TLR4,
we observed partial reduction of both HK- and live M.cat-induced
TNF-a and IL-6 secretion in TLR2
2/2 macrophages.
Pam3CSK4 was used as a synthetic ligand for TLR2 and failed
to induce cytokine secretion in TLR2
2/2 macrophages compared
to WT control. Together, these data show that TLR2 is partially
responsible for M. cat-induced host responses.
M.cat initiates host response through TLR2/TLR4/TLR9
Bacterial DNA often contains unmethylated CpG containing
DNA motifs that can be specifically recognized by TLR9. In fact,
pneumococcal and NTHi DNA have been reported as virulence
factors in pathogenesis caused by S.pneumoniae and nontypeable
Haemophilus influenza, respectively [14], [30]. Since we found only
partial reduction of M.cat-induced cytokine secretion in both
TLR2- and TLR4-deficient cells, we hypothesized that there must
be additional receptors responsible for host response and M. cat
DNA might be another potent virulence factor. In order to test our
hypothesis, we generated TLR2
2/2/TLR4
2/2/TLR9
2/2 triple
knockout mice. We treated the BMMØ as described earlier with
LOS, Pam3CSK4, CpG DNA, live and HK M.cat and measured
TNF-a and IL-6 in culture supernatants after 6 hours of
incubation. As expected, LOS, Pam3CSK4, and CpG DNA
induced production of both TNF-a and IL-6 was completely
abolished in TLR2
2/2/TLR4
2/2/TLR9
2/2 triple knockout
macrophages compared to WT control cells (Fig. 4 A–B). In
addition, we found TLR2/4/9 triple knockout macrophages
secreted minimal levels of cytokines in response to either live or
HK M. cat. Together, these critical data confirm that host response
against M. cat depends on combined recognition of TLR2, TLR4,
and TLR9.
M.cat induces host response through both MyD88- and
TRIF-dependent signaling pathway
After recognition of bacterial pathogen by various TLRs,
distinct intracellular pathways are activated that include different
Figure 1. Membrane bound CD14 is required for LOS but not whole M.cat induced host response. (A, B) BMMØ, (C) total splenocytes
were generated from CD14 knock-out and WT control mice (C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well as described in
materials and methods. Cells were then treated with LOS (100 ng/ml), LPS (100 ng/ml), Pam3 (10 mg/ml), HK and live M.cat (m.o.i-1:10) for 6 and
18 hours, respectively. Supernatants were collected and the levels of TNF-a (A), IL-6 (B) and IFN-c (C) were measured by ELISA. Representative data
from two independent experiments are shown.
doi:10.1371/journal.pone.0037610.g001
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containing adaptor protein inducing IFN-b (TRIF) [3]. All TLRs
(TLR2, TLR4, TLR9) that are responsible for M. cat recognition
share a common adapter molecule, MyD88. We next investigated
the function of MyD88 in M. cat-induced host responses in murine
macrophages. WT and MyD88
2/2 BMMØ were treated with
LOS and live or HK M.cat and measured production of TNF-a
and IL-12 p40 in culture supernatants. As expected, secretion of
both the cytokines was severely impaired in MyD88
2/2 mice
compared to WT control cells (Fig. 5 A–B). To confirm that
MyD88
2/2 macrophages have a functional MyD88-independent
signaling pathway, we measured gene expression of RANTES, a
cytokine that exclusively depends on the adapter molecule TRIF.
As expected, there was no difference in RANTES gene expression
in both WT and MyD88
2/2 macrophages in response to M. cat-
derived stimulation (Fig. 5C).
Among all the TLRs, only TLR4 has the unique ability to
initiate signaling pathway through both MyD88- and TRIF-
dependent pathways [4]. TRIF is also the adapter utilized by
TLR3 that recognizes double-stranded RNA. Since M.cat stimuli is
recognized by TLR4 (Fig. 2), it was reasonable to hypothesize that
M.cat also has the ability to initiate TRIF-dependent host response.
In fact, Fig. 6 shows that LOS, and live and HK M.cat induce
secretion of IFN-b and RANTES (both are TRIF-dependent) gene
expression in WT macrophages. However, the levels of IFN-b and
RANTES were severely impaired in macrophages generated from
TRIF
2/2 mice. The TLR3 ligand Poly I:C was used as a positive
control for this study. Interestingly, we found a complete reduction
of IL-6 secretion in response to M.cat stimuli in TRIF
2/2
macrophages compared to WT cells (Fig. 6C). An earlier study by
Yamamoto et al. also showed that inflammatory cytokines,
including IL-6, was severely impaired in TRIF-deficient macro-
Figure 2. Partial contribution of TLR4 in M. cat induced host response. BMMØ were generated from TLR4-deficeint and WT control mice
(C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well. Cells were then treated with LOS (100 ng/ml), LPS (100 ng/ml), HK and live
M.cat as described for 6 h (A) or 18 h (B). Supernatants were collected and the levels of TNF-a (A) and IL-12p40 (B) were measured by ELISA.
Representative data from two independent experiments are shown.
doi:10.1371/journal.pone.0037610.g002
Figure 3. Partial contribution of TLR2 in M. cat induced host response. BMMØ were generated from TLR2-deficient and WT control mice
(C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well. Cells were then treated with LOS (100 ng/ml), LPS (100 ng/ml), Pam3
(10 mg/ml), HK and live M.cat as described in materials and methods for 6 h. Supernatants were collected and the levels of TNF-a (A) and IL-6 (B) were
measured by ELISA. Representative data from two independent experiments are shown.
doi:10.1371/journal.pone.0037610.g003
M.cat Induced Innate Immune Response
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[6].
Inhibition of MAP kinase impairs M.cat induced cytokine
secretion
Once TLRs are activated, they recruit the MyD88 adapter
protein that, in turn, recruits the IL-1 receptor to IR-1R-
associated protein kinase (IRAK-1). IRAK-1 becomes phosphor-
ylated and subsequently degraded leading to recruitment of
TRAF6 to the growing receptor complex. This process results in
the activation of mitogen activated protein kinase (MAPK) that
involve the c-Jun NH2-terminal (JNK1/2) kinase, extracellular
signal-regulated kinase (ERK1/2) and p38 mitogen activated
protein (MAP) kinase and transcription factor NF-kB [31].
Previously, we found that TLR2 and TLR4 are only partially
responsible for M.cat-induced TNF-a secretion (Fig. 2, 3). Based on
the above data, we hypothesized that M.cat most likely activates
MAPK, in addition to recognition by TLR4. To test our
hypothesis, we took total splenocytes from TLR4-deficient mice
and pretreated them with various MAP kinase inhibitors such as
SP600125 (JNK1/2 kinase inhibitor), SB202190 (p38 MAP kinase
inhibitor), and U0126 (ERK1/2 kinase inhibitor), followed by
stimulation with HK and live M.cat, and measured TNF-a
secretion in the culture supernatants. Similar to BMMØ (Fig. 2),
total splenocytes from TLR4-deficient macrophages showed
partial reduction of TNF-a secretion compared to WT control
macrophages (Fig. 7). However, in TLR4-deficient cells pretreated
with either JNK1/2 or p38 inhibitor, absolutely no TNF-a was
found in culture supernatant. In contrast, inhibition of ERK1/2
had no effect on M.cat-induced TNF-a production. Together,
these data showed that M.cat is able to initiate host response
through TLR4-MAPK signaling pathway in murine macrophages.
TLR4 contributes to pulmonary clearance of M.cat in vivo
Having established that M.cat initiates host inflammatory
response through multiple toll like receptors and TLR4 at least
partially responsible for the production of pro-inflammatory
cytokines, we were interested to study the relative contribution
of TLR4 in host defense against M.cat in vivo. TLR4 mutant mice
C3H/HeJ and control mice C3H/OuJ were challenged with M.
catarrhalis type A strain in an aerosol chamber and then the mice
were euthanized at 3, 6, 12, and 24 h of post challenge, lungs were
collected, homogenized and used for cytokine detection and also
cultured on chocolate agar plates for bacterial counts. Live M.cat
induced high levels of TNF-a in lung homogenates from WT mice
as early as 3 h of post-challenge and then the level of TNF-a
gradually decreased (Fig. 8A). Within 12 h, very little TNF-a was
found and was almost absent at 24 h of post-challenge. On the
other hand, secretion of TNF-a in response to M.cat was severely
impaired in lungs from TLR4 mutant, C3H/HeJ mice. In fact,
M.cat induced TNF-a was more significantly reduced in vivo
compared to in vitro. Levels of IL-6 production in lung homogenate
were also examined. Fig. 8B shows that M.cat induced production
of IL-6 in WT mice as early as 3 h, but reached its peak at 6 h
post-challenge then slowly decreased, but remained well above
background levels, even after 24 h. IL-6 production was also
significantly reduced in lungs from TLR4 mutant mice compared
to WT mice (Fig. 8B). The relative contribution of TLR4 in
bacterial clearance from lung was also assessed and a different
trend was observed between WT and TLR4-defective mice. At
earlier time points, M.cat was cleared more efficiently and
significantly in TLR4 mutant mice compared to wild type mice
and this trend continued until 6 h (p,0.05). However, at 12 h,
bacterial loads were two times higher in mutant mice than in wild
type control mice and remains significantly high at 12 h (p,0.001)
and even after 24 h of post-challenge (Table 1). Together, these
data provide strong evidence that multiple TLRs play a key role in
M.cat induced host inflammatory response and mutation of TLR4
gene impairs the host ability to efficiently clear the bacterial loads
from lungs in vivo.
Discussion
Moraxella catarrhalis is an unencapsulated, Gram-negative human
respiratory pathogen. There are total of three serotypes of M.cat,
with type A being most prevalent (61%), followed by type B and C
(29% and 5%) [32]. In the present study, purified LOS from M.cat
type A (ATCC 25238), or live or HK bacteria were used to
stimulate murine macrophages generated from series of TLR and
Figure 4. Recognition of M.cat by host depends on combined effect of TLR2/4/9. BMMØ were generated from TLR2/4/9 triple knock-out
and WT control mice (C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well. Cells were then treated with LOS (100 ng/ml), Pam3
(10 mg/ml), CpG DNA (20 mg/ml), HK and live M.cat for 6 h. Supernatants were collected and the levels of TNF-a (A) and IL-6 (B) were measured by
ELISA. Representative data from two independent experiments are shown.
doi:10.1371/journal.pone.0037610.g004
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the host response was investigated . We found that LOS and whole
bacteria initiate distinct signaling pathways through one or more
TLRs and is able to activate both MyD88- and TRIF-dependent
signaling pathways in vitro. While LOS required only CD14-TLR4
complex and was able to initiate both MyD88- and TRIF-
dependent host responses, both live and HK M.cat required
multiple TLRs (TLR2, TLR4 and TLR9) and recognition of
whole bacteria did not necessarily require CD14. Finally, we
showed that TLR4 mutant mice produced significantly reduced
levels of pro-inflammatory cytokines such as TNF-a and IL-6 in
response to live M.cat and had significantly higher level of bacterial
loads in the lungs compared to WT control mice.
Similar to Neisseria spp., M. cat possesses an LOS that is similar
in structure to, but distinct from the structure of LPS that is found
in the outer membrane of most Gram negative bacteria. The LOS
of M. cat is highly conserved among 95% of known M. cat strains
and clinical isolates [32], [33]. Despite these structural differences
between LOS and LPS, we found that both induce essentially the
same levels of cytokines in WT murine macrophages, CD14
2/2
macrophages, and in TLR4
2/2 macrophages, indicating that
both the E. coli LPS and the M. cat LOS are strictly TLR4 agonists.
Since LOS lacks a repeating O antigen polysaccharide, and
possesses a 2 heptose ‘‘core,’’ its structure resembles that of a rough
LPS [32]. In contrast to a previous paper claiming that smooth,
but not rough, LPS preparations utilized CD14 [34], we found
that CD14 is absolutely required for LOS-induced secretion of
pro-inflammatory cytokines. Production of TNF-a, IL-6, and IFN-
c were severely impaired in CD14-deficient murine macrophages
compared to WT cells. In contrast, CD14 was not necessary for
the induction of TNF-a and IFN-c by HK and live M. cat and only
partially required for IL-6 production. Similar types of results also
have been reported. Catharina et al. found elevated levels of IL-1b,
IL-6, and TNF-a in lungs from CD14 knock-out mice compared
Figure 5. Impaired immune response to M.cat by MyD88 deficient macrophages. BMMØ were generated from MyD88 knock-out and wild
type control mice (C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well. Cells were then treated with LOS (100 ng/ml), HK and live
M.cat for 6 h (A) or 18 h (B, C). A–B, Supernatants were collected and the levels of TNF-a (A) and IL-12p40 (B) were measured by ELISA. C. Total RNA
was extracted after 18 h of M.cat treatment and gene expression of RANTES was analyzed by real time RT-PCR. Representative data from three
independent experiments are shown.
doi:10.1371/journal.pone.0037610.g005
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discrepancy between the production of TNF-a and IL-6 by M. cat
and the role of CD14 remains elusive and needs further
investigation. Once CD14 brings monomeric LPS to TLR4-
MD2 complex, it initiates TLR4-mediated signaling and subse-
quent cytokine production. Similar to CD14, TLR4 was also
found to be absolutely required for LOS-induced secretion of
TNF-a and IL-12, whereas TLR4 was only partially responsible
for either HK- or live M.cat-induced cytokine secretion, suggesting
that CD14-TLR4 complex is absolutely important for host
recognition of M. cat LOS by host, while HK or live M. cat are
recognized by other receptors as well. Similar partial inhibition of
cytokine secretion was also observed in TLR2-deficient macro-
phages. These results led us into search for additional TLRs that
might be responsible for M.cat recognition. In TLR2/TLR4/
TLR9 triple knockout macrophages generated from triple
knockout mice failed to secrete significant levels of pro-inflamma-
tory cytokines in response to LOS, HK, or live M.cat (Fig. 4).
Together, these data firmly established our hypothesis that M.cat is
recognized by host innate immunity that primarily involves TLR2,
TLR4 and TLR9.
Once innate immunity is activated by various microbial stimuli
through multiple TLRs, different adapter molecules bind to the
intracellular domain of their specific TLR and initiate a series of
intracellular signaling cascades such as MAPK and transcription
factor NF-kB. MAPKs are Ser/Thr kinases that convert
extracellular stimuli to intracellular signaling and regulate wide
range of cellular functions such as gene expression, mitosis,
metabolism, motility, survival, apoptosis and differentiation [35].
Although there are total of 14 MAPKs so far have been identified,
three are most widely studied (i) extracellular signal regulated
kinase 1/2 (ERK1/2), (ii) p38 MAP kinase and (iii) c-Jun N-
terminal kinase 1/2 (JNK1/2). In our study, we found that prior
inhibition of p38 MAPK and JNK1/2 by pharmacological
inhibitor completely abolished secretion of TNF-a in response to
M.cat stimuli in TLR4-deficient total splenocytes which otherwise
was seen only partial inhibition in the same knockout mice. So far,
we have provided strong evidence to establish that the host
Figure 6. Impaired immune response to M.cat by TRIF-deficient macrophages. Bone marrow derived macrophages were generated from
TRIF knock-out and wild type control mice (C57BL/6J) and cultured in 24 well tissue culture plate at 2610
5 cells/well. Cells were then treated with LOS
(100 ng/ml), Poly I:C (50 mg/ml), HK and live M.cat for 18 h (A–B) or 6 h (C). A, C, Supernatants were collected and the levels of IFN-b (A) and IL-6 (C)
were measured by ELISA. B. Total RNA was extracted after 18 h of M.cat treatment and gene expression of RANTES was analyzed by real time RT-PCR.
Representative data from two independent experiments are shown.
doi:10.1371/journal.pone.0037610.g006
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JNK1/2. The relative contribution of two major adapter
molecules, MyD88 and TRIF, in M.cat-induced host immune
responses were also investigated. From our results, it was obvious
that M.cat would certainly initiate the signaling pathway which
would be largely dependent on MyD88 adapter molecule and
found that M.cat induced secretion of MyD88-dependent pro-
inflammatory cytokines was totally absent in macrophages
generated from MyD88 deficient mice compared to control
macrophages (Fig. 5). Considering the fact that LOS and LPS
have different chemical structures, we were further interested to
find out whether or not, LOS or HK and live M.cat are able to
initiate MyD88-independent, TRIF dependent signaling pathway
in murine macrophages. In fact, Fig. 7 shows that LOS or HK and
Live M.cat also have the ability to induce IFN-b secretion and
RANTES gene expression, two cytokines that are well known as a
result of activation of TRIF dependent signaling pathway. Further,
we found that M. cat-induced production of IFN-b and expression
of RANTES was completely impaired in macrophages from
TRIF-deficient mice.
Many recent studies have investigated the role of TLRs in host
defense against Gram negative bacterial infection in lung. It has
been found that TLR4 significantly contributes to protective
immune responses [36]. Moreover, a significantly higher incidence
of bacterial infection has been reported in intensive care unit
patients with TLR4 mutations [37]. When NTHi was injected in
Figure 7. M.cat induces host response through TLR4-MAP
kinase signaling pathway. Total splenocytes were isolated from
TLR4 knock-out and WT control mice (C57BL/6J) and cultured in 24 well
tissue culture plate at 2610
5 cells/well and pretreated with p38
inhibitor SB202190 (10 mM), JNK1/2 inhibitor SP600125 (10 mM) and
ERK1/2 inhibitor U0126 (10 mM) for 1 h followed by treatment with
either HK or live M.cat for 18 h. Supernatants were collected and the
levels of TNF-a were measured by ELISA. Representative data from two
independent experiments are shown.
doi:10.1371/journal.pone.0037610.g007
Figure 8. Reduced cytokines production in lung from TLR4 mutant mice in response to live M.cat in vivo. TLR4 mutant mice C3H/HeJ and
wild type control mice C3H/OuJ were challenged with live M.cat type A strain at 1610
8 CFU/ml in an aerosol chamber as described in materials and
methods. Lungs were collected at 3, 6, 12 and 24 h, homogenized and levels of TNF-a (A) and IL-6 (B) were measured by ELISA. (n=6 for each time
point).
doi:10.1371/journal.pone.0037610.g008
Table 1. Pulmonary clearance patterns in TLR4 mutant C3H/
HeJ and wild type control C3H/OuJ mice after an aerosol
challenge with M. catarrhalis type A.
Time WT TLR4 mutant
3 h 4750065708 3433362124
ns
6 h 2966663018 1516661518
*
12 h 19756386 39506423
**
24 h 4265 204665
**
Post-challenge
a bacterial Recovery
b [CFU/lung (SD range)].
aGroups of six mice at each time point were challenged with 1610
8 CFU of
M.cat in an aerosol chamber.
bNumber of viable bacteria that are recovered at 3, 6, 12 and 24 hours.
*Significant decrease of number of bacteria was observed in TLR4 mutant mice
(p,0.05 vs WT control).
**Significant increase of number of bacteria was observed in TLR4 mutant mice
(p,0.001 vs WT control).
nsNot significant.
Data are expressed as mean 6SEM.
doi:10.1371/journal.pone.0037610.t001
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acute otitis media was prolonged to 48 hours compared to control
mice [38]. Consistent with these observations, we also found that
at initial time points after bacterial challenge, e.g., 6 hours,
bacterial loads were, in fact, significantly lower in TLR4 mutant
mice compared to wild type mice (p,0.05), despite the fact that at
the same time mutant mice produced significantly less amount of
pro-inflammatory cytokines. However, with time, mutant mice
were clearly less able to clear M.cat from their lungs and at
24 hours, the number of viable bacteria was five times higher than
the WT mice (p,0.001). It is possible that either less polymor-
phonuclear cells (PMNs) are recruited to lungs in mutant mice or
have the impaired ability to phagocytosis the bacteria, resulting in
an increased number of bacteria at the later time points. However,
it is also possible that other factors such as complements play a
crucial role in early reduction of bacterial loads.
In this report, we have clearly identified the specific signaling
pathways that lead to activation of host immune responses in
response to M.cat LOS or whole bacteria. We have shown that
while LOS absolutely requires CD14 and TLR4, it does not
require TLR2; however, whole M. cat shows a partial requirement
for CD14, TLR2, TLR4, and TLR9, possibly reflecting the
concurrent expression of distinct PAMPs on the organism. Despite
the structural differences between LPS and LOS, like LPS, LOS
also has the ability to induce both MyD88 dependent and TRIF
dependent signaling pathway through TLR4. On the other hand,
recognition of whole M.cat requires multiple TLRs and in addition
to MyD88 and TRIF adaptor molecules, it also induces secretion
of pro-inflammatory cytokines through MAP kinase.
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